| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5592835 | Cardiovascular Revascularization Medicine | 2017 | 5 Pages |
Abstract
The use of an ePTFE-covered nitinol self-expanding stent graft placed in the common femoral artery for the treatment of suture-mediated pre-closure device failure following transcatheter aortic valve replacement (TAVR) is described in 25 patients. Its use was found to be feasible, safe, and an effective treatment modality for access site-related vascular complications following TAVR.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Arie Steinvil, Nelson Bernardo, Toby Rogers, Edward Koifman, Kyle Buchanan, M. Chadi Alraies, Christian Shults, Rebecca Torguson, Petros G. Okubagzi, Augusto D. Pichard, Lowell F. Satler, Itsik Ben-Dor, Ron Waksman,